DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Flow Cytometry Market Analysis By Technology (Cell-Based, Bead-Based), By Application (Research, Industrial, Clinical), By End-use (Commercials, Hospitals, Academics, Clinical Labs), By Product & Services, And Segment Forecasts, 2014 - 2025" report to their offering.
The global flow cytometry market is expected to reach USD 8.0 billion by 2025
The increasing incidence of infectious diseases and cancer is expected to upsurge the demand for flow cytometers for use in disease diagnosis over the coming years. In addition, higher number of physicians is inclined toward the usage of autologous and allogenic stem cell therapy, due to adverse effects caused by chemotherapy & radiation therapy in the treatment of cancer, thereby affecting the growth of this market.
Moreover, rising demand for point-of-care testing in chronic diseases management is expected to fuel the demand for cytometry techniques. Rising implementation of microfluidic miniature flow cytometry in point-of-care diagnostics is the factor augmenting the future growth. Increasing R&D initiatives by various key players for the development of multicolor assays and advanced reagents for analysis are anticipated to boost the usage rate. Advancement in technology for the purpose of enhanced accuracy, portability, and cost-effectiveness is expected to serve this market with lucrative growth opportunities.
Small-size high-throughput cytometers are expected to gain popularity over the coming years due to associated benefits such as ease in use and cost-effectiveness. Furthermore, improvement in fluorescent dyes & introduction of bench top cytometers are the other growth propellers. For instance, multicolor flow cytometry coupled with multiple lasers is the fastest growing application segment, which finds extensive applications in the field of R&D innovations in new drug development and is adopted by many contract research organizations.
Flow Cytometry Market Variables, Trends & Scope
Market driver analysis
- Growing prevalence of target disorders
- Increasing demand for in vitro diagnostics
- Growing R&D investments in biotechnology sector
- Technological advancements
- Increasing demand for point of care diagnostics
Market restraint analysis
- High cost of instruments
- Danaher Corporation
- Beckman Coulter
- Becton, Dickinson and Company
- Sysmex Corporation
- Agilent Technologies
- Merck & Co., Inc.,
- Apogee Flow Systems
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Luminex Corporation
- Miltenyi Biotec
- GE Healthcare
For more information about this report visit http://www.researchandmarkets.com/research/mmnrzr/flow_cytometry